thymoquinone has been researched along with Experimental Hepatoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eissa, LA; El Gayar, AM; El-Karef, A; El-Mesery, M; Helmy, SA | 1 |
| Anandakumar, P; Asokkumar, S; Binuclara, J; Devaki, T; Jagan, S; Naveenkumar, C; Paramasivam, A; Raghunandhakumar, S; Senthilraja, S | 1 |
2 other study(ies) available for thymoquinone and Experimental Hepatoma
| Article | Year |
|---|---|
Thymoquinone upregulates TRAIL/TRAILR2 expression and attenuates hepatocellular carcinoma in vivo model.
Topics: Animals; Apoptosis; Benzoquinones; Carcinoma, Hepatocellular; Cell Proliferation; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Liver Neoplasms, Experimental; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptors, TNF-Related Apoptosis-Inducing Ligand; TNF-Related Apoptosis-Inducing Ligand | 2019 |
Thymoquinone inhibits cell proliferation through regulation of G1/S phase cell cycle transition in N-nitrosodiethylamine-induced experimental rat hepatocellular carcinoma.
Topics: Animals; Benzoquinones; Cell Cycle Proteins; Cell Proliferation; Diethylnitrosamine; G1 Phase Cell Cycle Checkpoints; Immunoblotting; Ki-67 Antigen; Liver Neoplasms, Experimental; Male; Proliferating Cell Nuclear Antigen; Random Allocation; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Specific Pathogen-Free Organisms | 2013 |